Companies: 10,795·Total market cap: $144.5T
Alto Neuroscience, Inc.

Alto Neuroscience, Inc.

ANRONYSEHealthcare● Active
$18.26
$0.00(-0.05%)
Market Cap$640815344
P/E Ratio
52W High$28.441
52W Low$2.15

Alto Neuroscience, Inc. (ANRO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

anro · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 8 Wall Street analysts in the past 3 months

SellBuy

Buy

8 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
7
Hold
1
Sell
0
Strong Sell
0
Total: 8 · Buy rate: 87.5%

12-Month Price Target

High

$50.00

Consensus

$34.60

+88.3% upside

Low

$24.00

Median: $35 · Last Close: $18.38

The Alto Neuroscience, Inc. (ANRO) analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month ANRO price target is $34.60, representing +88.3% upside from the current price of $18.38.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $35 (88.3%)

Consensus Target

$34.60

88.3% upside

High Target

$50

172.1%

Low Target

$24

30.6%

Current Price

$18.38

as of today

Based on analyst price targets, the ANRO stock price prediction for the next 12 months ranges from $24 to $50. The consensus ANRO price forecast of $34.60 implies 88.3% upside from the current price of $18.38.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$17.465.00%

1-day model range: $17.31–$17.61. Peak: $17.61 (-5.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%14%79%
1Buy
2Neutral
11Sell
RSI (14)29.8Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ANRO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$18.85SELL
MA 10$19.58SELL
MA 20$21.01SELL
MA 50$22.94SELL
MA 100$20.85SELL
MA 200$0.00NEUTRAL
Current $ANRO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$18.92SELL
EMA 10$19.57SELL
EMA 20$20.70SELL
EMA 50$21.67SELL
EMA 100$20.48SELL
EMA 200$0.00NEUTRAL
Current $ANRO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Baird2026-05-18
Maintains
OutperformOutperform
Wedbush2026-05-14
Maintains
NeutralNeutral
HC Wainwright & Co.2026-05-11
Maintains
BuyBuy
Chardan Capital2026-04-22
Maintains
BuyBuy
Baird2026-04-02
Maintains
OutperformOutperform
Wedbush2026-04-02
Maintains
NeutralNeutral
HC Wainwright & Co.2026-04-02
Maintains
BuyBuy
Chardan Capital2026-04-02
Maintains
BuyBuy
Jones Trading2026-04-02
Maintains
BuyBuy
Baird2026-03-18
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Alto Neuroscience, Inc. (ANRO) stock. Of the recent 26 rating actions, 0 were upgrades and 1 were downgrades. 8 analysts currently cover ANRO.

Analyst Recommendation Trends

Buy ratings22
Hold ratings01↑ +1
Sell ratings00

ANRO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$0M

EPS This Year

$-3.00

EPS Next Year

$-3.23

↑ 7.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ANRO EPS of $-3.00 for the current fiscal year, based on estimates from 8 analysts. The ANRO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ANRO stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ANRO price target is $34.60 (+88.3% upside), with an analyst consensus of Buy.

The ANRO short-term stock prediction for tomorrow is $17.46 (-5.00%).

Alto Neuroscience, Inc. trades on NYSE under the ticker ANRO. The ANRO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 88% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ANRO forecast · 8 questions

According to 8 Wall Street analysts, the average 12-month ANRO price target is $34.60, with a high forecast of $50.00 and a low of $24.00. The median price target is shown in the chart above when available. This implies +88.3% potential upside from the current price of $18.38.

ANRO price targetWhat is ANRO price targetANRO analyst price targetANRO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.